Dow Up1.31% Nasdaq Up2.40%

PharmAthene, Inc. (PIP)

-NYSE MKT
1.72 0.03(1.71%) Oct 21, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 17,913   25,176   24,266  
Cost of Revenue -   -   -  
Gross Profit 17,913   25,176   24,266  
Operating Expenses
Research Development15,290  19,510  21,220  
Selling General and Administrative13,279  11,629  14,311  
Non Recurring -   -   -  
Others182  304  461  
Total Operating Expenses -   -   -  
Operating Income or Loss (10,839) (6,266) (11,726)
Income from Continuing Operations
Total Other Income/Expenses Net(448)1,884  7,983  
Earnings Before Interest And Taxes(11,287)(4,382)(3,743)
Interest Expense369  343  55  
Income Before Tax(11,657)(4,725)(3,798)
Income Tax Expense62  196   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(11,718)(4,920)(3,798)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (11,718) (4,920) (3,798)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (11,718) (4,920) (3,798)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.